We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01627678
Recruitment Status : Completed
First Posted : June 26, 2012
Last Update Posted : January 14, 2014
Information provided by (Responsible Party):
Bionor Immuno AS

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2013
  Study Completion Date : November 2013